FILE - The Peloton logo is seen on the company's stationary bicycle in San Francisco, Calif., Nov. 19, 2019. (AP Photo/Jeff Chiu, File)

Peloton is recalling nearly 878,000 exercise bikes in the U.S. and Canada — due to seat posts that can break during use and pose fall hazards. Notices from the U.S. Consumer Product Safety Commission and Health Canada on Thursday say the recall affects certain “Peloton Original Series Bike+” units with model number PL02.

Peloton has received three reports of seat posts breaking in the U.S., with two resulting in injuries. No incidents have been reported in Canada. Peloton urges owners to stop using the bikes and contact the company for a free seat post replacement.

Musk could become history’s first trillionaire

NEW YORK — The world’s richest man was just handed a chance to become history’s first trillionaire. Elon Musk won a shareholder vote on Thursday that would give the Tesla CEO stock worth $1 trillion if he hits certain performance targets over the next decade.

The vote followed weeks of debate over his management record and whether anyone deserved such unprecedented pay, drawing heated commentary from small investors to giant pension funds and even the pope. It was a resounding victory for Musk, showing that investors still have faith in him as the car company struggles with plunging sales and profits.

Trump has other options if tariff plan gets nixed

President Donald Trump has warned that the Supreme Court will leave the United States “defenseless” and possibly “reduced to almost Third World status” if it strikes down the tariffs he imposed this year on nearly every country on earth.

The truth, though, is that Trump will still have plenty of options to keep taxing imports aggressively even if the justices rule against him. He can re-use tariff powers he deployed in his first term and can reach for others, including one that dates back to the Great Depression.

Deal to expand coverage on obesity drugs unveiled

President Donald Trump has unveiled a deal with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy. The drugs are part of a new generation of obesity medications known as GLP-1 receptor agonists that have soared in popularity in recent years.

But access to the drugs has been a consistent problem for patients because of their cost and spotty insurance coverage. The announcement is the latest attempt by the Trump administration to rein in soaring drug prices in its efforts to address cost-of-living concerns among voters.

Street loses ground as tech stocks fall

Wall Street lost ground as influential technology stocks fell and once again steered the broader market. The S&P 500 fell 1.1% Thursday.

The Dow Jones Industrial Average fell 0.8%, and the Nasdaq composite lost 1.9%. DoorDash sank after warning investors that it will be spending much more on product development next year. CarMax lost almost a quarter of its value after forecasting earnings far below what analysts were expecting and announcing that its CEO is leaving.

Report: Pilot didn’t recall instructions before collision

The captain of a Delta Air Lines regional jet involved in a collision at LaGuardia Airport last month told investigators he did not recall hearing instructions to yield to another plane.

The National Transportation Safety Board released a preliminary report on Thursday. The incident occurred on Oct, 1 when a plane bound for Roanoke, Virginia, collided with another arriving from Charlotte, North Carolina.